Authors: Mullen, G Napier, J Balestra, M DeCory, T Hale, G Macor, J Mack, R Loch, J Wu, E Kover, A Verhoest, P Sampognaro, A Phillips, E Zhu, YY Murray, R Griffith, R Blosser, J Gurley, D Machulskis, A Zongrone, J Rosen, A Gordon, J

Citation: G. Mullen et al., (-)-spiro[1-azabicyclo[2.2.2]octane-3,5 '-oxazolidin-2 '-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor, J MED CHEM, 43(22), 2000, pp. 4045-4050